Amneal Pharmaceuticals (AMRX) Return on Sales [ROS] (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted Return on Sales [ROS] of 16.30% for Q2 2026, up 0.93 percentage points from 15.37% a year earlier but down 3.32 percentage points from the prior quarter.
Amneal Pharmaceuticals (AMRX) Return on Sales [ROS] (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Amneal Pharmaceuticals was 14.56%, up 1.37 percentage points year-over-year; for FY2025, it came in at 13.05%, up 4.13 percentage points from FY2024.
- Annual Return on Sales [ROS] has increased for three consecutive years, with a five-year change of +8.48 percentage points (FY2020 to FY2025).
- In prior years, Amneal Pharmaceuticals' Return on Sales [ROS] was 8.92% in FY2024 (+0.39 pp), 8.54% in FY2023 (+12.83 pp), -4.29% in FY2022 (-11.59 pp) and 7.29% in FY2021 (+2.72 pp).
- Quarterly Return on Sales [ROS] has run from a low of -35.51% in Q2 2022 to a high of 19.62% in Q1 2026 over five years.
- On a year-over-year basis, Return on Sales [ROS] has increased in each of the last three quarters, with an average year-over-year change of +4.02 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q2 2023, with a gain of 48.88 percentage points; the weakest was Q2 2022, with a drop of 48.05 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was 19.62% (Q1 2026), 13.76% (Q4 2025) and 8.97% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Amneal Pharmaceuticals | 6.48 Bn | 5.76 Bn | 334.51 Mn | 16.30% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.30% |
| Mar 31, 2026 | 19.62% |
| Dec 31, 2025 | 13.76% |
| Sep 30, 2025 | 8.97% |
| Jun 30, 2025 | 15.37% |
| Mar 31, 2025 | 14.43% |
| Dec 31, 2024 | 10.38% |
| Sep 30, 2024 | 12.64% |
| Jun 30, 2024 | 13.60% |
| Mar 31, 2024 | -1.63% |
| Dec 31, 2023 | 2.30% |
| Sep 30, 2023 | 12.20% |
| Jun 30, 2023 | 13.37% |
| Mar 31, 2023 | 6.18% |
| Dec 31, 2022 | 5.91% |
| Sep 30, 2022 | 8.13% |
| Jun 30, 2022 | -35.51% |
| Mar 31, 2022 | 4.68% |
| Dec 31, 2021 | 2.08% |
| Sep 30, 2021 | 5.39% |
Amneal Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=AMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();